INGN logo

INGN
Inogen Inc

1,467
Mkt Cap
$192.64M
Volume
82.00
52W High
$9.13
52W Low
$5.34
PE Ratio
-8.46
INGN Fundamentals
Price
$7.25
Prev Close
$7.05
Open
$7.05
50D MA
$6.33
Beta
1.18
Avg. Volume
261,141.54
EPS (Annual)
-$0.8551
P/B
1.03
Rev/Employee
$463,038.51
$75.37
Loading...
Loading...
News
all
press releases
Inogen (NASDAQ:INGN) Stock Price Passes Above 50 Day Moving Average - Here's What Happened
Inogen (NASDAQ:INGN) Stock Price Passes Above Fifty Day Moving Average - Here's What Happened...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Inogen to Report First Quarter 2026 Financial Results on May 7, 2026
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report first quarter 2026 financial results after the market closes on Thursday, May 7, 2026. On the same day, the Company will host a...
Business Wire·5d ago
News Placeholder
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
INGN rides surging POC demand and global growth tailwinds, but U.S. channel shifts and macro risks may weigh on near-term performance.
Zacks·6d ago
News Placeholder
Beta Bionics, Inc. (BBNX) Reports Q1 Loss, Misses Revenue Estimates
Beta Bionics, Inc. (BBNX) delivered earnings and revenue surprises of +8.24% and -0.45%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·7d ago
News Placeholder
Inogen Unveils Growth Plan at Needham Conference: New CFO, Voxi 5, Simeox and Aurora Mask Push
Inogen (NASDAQ:INGN) executives used a fireside chat at the 25th Annual Needham Healthcare Conference to outline the company's strategic priorities, discuss its product expansion beyond portable oxygen concentrators, and address recent financial trends. The session was hosted by Needham & Compan...
MarketBeat·12d ago
News Placeholder
Inogen (INGN) Surges 6.9%: Is This an Indication of Further Gains?
Inogen (INGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks·20d ago
News Placeholder
Inogen Announces the Appointment of Vafa Jamali to Board of Directors
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Vafa Jamali as an independent...
Business Wire·22d ago
News Placeholder
Inogen Announces Participation in the 25th Annual Needham Virtual Healthcare Conference
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that Kevin Smith, President and Chief Executive...
Business Wire·28d ago
News Placeholder
Inogen, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Compensation Committee of Inogens Board of...
Business Wire·29d ago
News Placeholder
Inogen Announces Leadership Appointments Designed to Accelerate Next Phase of Growth
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the following leadership appointments designed to...
Business Wire·29d ago
<
1
2
...
>

Latest INGN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.